Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
August 31, 2018
The article focuses on FDNA’s pioneering efforts to address rare disease disorders through advanced AI technology. FDNA’s Face2Gene platform leverages artificial intelligence and facial recognition to identify rare genetic conditions by analyzing patients’ facial features. This innovative decision support tool aims to shorten the diagnostic journey, providing healthcare professionals with a powerful resource to detect rare disease disorders more accurately and efficiently. The article emphasizes how FDNA’s technology is transforming the landscape of genetic diagnostics, offering new avenues for early intervention and personalized care for individuals with rare conditions.
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…